Psychometric validation of measures of alcohol expectancies, retrospective subjective response, and positive drinking consequences for use with adolescents.

The Anticipated Effects of Alcohol Scale (AEAS), the Subjective Effects of Alcohol Scale, and the Positive Drinking Consequences Questionnaire (PDCQ) are psychometrically sound measures of alcohol expectancies (expectancies), subjective response to alcohol, and positive drinking consequences, respectively, for use with adults. Prior research using these measures suggests that expectancies, subjective response, and positive drinking consequences are related yet distinct determinants of drinking. The current study presents psychometric evaluations of these measures for use with adolescents including confirmatory factor analyses (CFA) of the previously identified latent structures, internal consistency, and test-criterion relationships. Legally, alcohol cannot be administered to adolescents, so we assessed retrospective subjective response (during the first drinking episode ever [SEAS First] and the most recent drinking episode [SEAS Recent]). The sample comprised 248 Connecticut high school students (53.6% male; mean age 16.50 [1.19] years; 71.4% White) who completed an anonymous survey. CFA confirmed the latent factor structures for each measure. The AEAS, SEAS First, SEAS Recent and the PDCQ were internally consistent (mean α AEAS=0.83; SEAS First=0.88; SEAS Recent=0.89, PDCQ=0.87). AEAS subscales evidenced moderate overlap with corresponding SEAS First subscales (mean=0.36) and SEAS Recent subscales (mean=0.46) and modest overlap with the PDCQ (mean=0.17). Expectancies, subjective response, and positive drinking consequences also accounted for significant variance in monthly drinking, lifetime maximum number of drinks consumed, and alcohol-related problems. In sum, the AEAS, the retrospective SEAS, and the PDCQ are psychometrically sound measures for use with adolescents.

FKBP5 variation is associated with the acute and chronic effects of nicotine.

Stress and hormones released in response to stress influence the effects of nicotine and the severity of nicotine withdrawal. Here, we systematically examine the contribution of a stress response gene, FKBP5, to the acute and chronic behavioral effects of nicotine in smokers. Subjects were European- and African-American (EA and AA) heavy smokers who participated in an intravenous (IV) nicotine administration study (total n=169). FKBP5 rs3800373 genotype was analyzed for association to several outcomes, including nicotine withdrawal and the acute subjective, heart rate (HR), blood pressure and plasma cortisol responses to IV nicotine. Nicotine withdrawal was also examined in relation to rs3800373 allele frequencies in an independent cohort of EA and AA current smokers (n=3821). For a subset of laboratory subjects FKBP5 mRNA (n=48) expression was explored for an association to the same outcomes. The rs3800373 minor allele was associated with less severe nicotine withdrawal in laboratory subjects and the independent cohort of smokers. The rs3800373 minor allele was also associated with lower subjective ratings of negative drug effects in response to IV nicotine. Low FKBP5 mRNA expression was associated lower cortisol levels, lower subjective ratings of negative drug effects and a blunted HR response to nicotine. Stress hormone regulation via FKBP5 warrants further investigation as a potential contributor to the effects of nicotine withdrawal, which occurs commonly, and has an important role in the maintenance of smoking behavior and relapse following a quit attempt.